Miller-Meeks, Crenshaw, and Khanna Applaud FDA Guidance on Clinical Trials With Psychedelics Following Legislative Push
July 01, 2023
July 01, 2023
WASHINGTON, July 1 -- Rep. Mariannette Miller-Meeks, R-Iowa, issued the following news release:
U.S. Representatives Mariannette Miller-Meeks (Iowa-01), Dan Crenshaw (Texas-02), and Ro Khanna (Calif.-17) applaud the FDA's decision to issue its first draft guidance on clinical trials for psychedelic drugs in treating mental health conditions like PTSD and TBI - following the introduction of his legislation calling on the FDA to do exactly that.
"Many Veterans find g . . .
U.S. Representatives Mariannette Miller-Meeks (Iowa-01), Dan Crenshaw (Texas-02), and Ro Khanna (Calif.-17) applaud the FDA's decision to issue its first draft guidance on clinical trials for psychedelic drugs in treating mental health conditions like PTSD and TBI - following the introduction of his legislation calling on the FDA to do exactly that.
"Many Veterans find g . . .